http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2538083-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eeba9a66ec23e6c798bf577b8fbb1f11 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-28 |
| filingDate | 2013-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_657d7bcaadd5f6dc197445202802795d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cdc0a285fdd5ba3fa00125043e84a7d |
| publicationDate | 2015-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2538083-C1 |
| titleOfInvention | Method of treating affection of vegetative parasympathetic nodes of head of herpes-virus etiology |
| abstract | FIELD: medicine. n SUBSTANCE: invention relates to medicine, namely to dentistry and maxillofacial surgery, and can be applied for treating affection of vegetative parasympathetic nodes of head of herpes-virus etiology. For this purpose introduced are: famciclovirum in dose 500 mg 3 times per day for 10 days, ketorop in dose 1 tablet 2 times per day after meal for 7 days, tavegyl in dose 1 tablet 1 time per day before going to bed for 10 days, neuromultivit in dose 1 tablet 2 times per day for 30 days, in addition, additionally introduced is viferon in form of rectal suppositories in dose 1 suppository (500000) 1 time per day for 10 days. Patient takes all medications mentioned above simultaneously. When the course of viferon intake is over, cycloferon in tablets is administered in tablets with dose 150 mg with the schedule of intake as follows: 1-st day - 1 tablet 2 times per day; 2-nd day - 1 tablet 1 time per day; 4, 6, 8, 11, 14, 17, 20, 23-rd day - 1 tablet 1 time per day, after intake of which administered is immunorm in dose 1 tablet 3 times per day for 30 days. n EFFECT: method makes it possible to increase therapeutic effect due to simultaneous impact on herpes virus and separate links of immunity with increase of remission and reduction of term of its development, absence of aggravations and long support of organism and virus equilibrium. n 2 tbl, 2 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2601408-C1 |
| priorityDate | 2013-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 414.